Imidazo[1,2-a]pyridin-8-amine dihydrochloride is primarily utilized in pharmaceutical research and development. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting central nervous system disorders. Its structural framework is often incorporated into molecules designed to interact with specific receptors or enzymes, making it valuable in the creation of potential therapeutic agents. Additionally, this compound is explored in the development of drugs for treating anxiety, insomnia, and other neurological conditions due to its ability to modulate neurotransmitter activity. Its application extends to preclinical studies, where it aids in understanding pharmacological mechanisms and optimizing drug efficacy.